Article Data

  • Views 233
  • Dowloads 119

Reviews

Open Access

A systemic review of human papillomavirus studies: global publication comparison and research trend analyses from 1993 to 2008

  • H.W. Lin1,2,3
  • T.C. Yu4
  • Y.S. Ho4,5,*,

1Armed Forces Taichung General Hospital, Taichung, Taiwan

2Central Taiwan University of Science and Technology, Taipei, Taiwan

3Department of Health Care Administration, College of Health Science, Asia University, Taichung, Taiwan

4Trend Research Centre, Asia University, Taichung, Taiwan

5Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan

DOI: 10.12892/ejgo201102133 Vol.32,Issue 2,March 2011 pp.133-140

Published: 10 March 2011

*Corresponding Author(s): Y.S. Ho E-mail: ysho@asia.edu.tw

Abstract

The term "human papillomavirus" has been used as the keyword during searching titles, abstracts, and keywords based on the online version of Science Citation Index (SCI), Web of Science from 1993 to 2008. Twelve document types were found among the 14,943 papers published in 1,072 journals that were listed in 99 SCI subject categories. All the articles referring to human papillomavirus were assessed by using the following aspects: characteristics of publication output, distribution of output in journals, publication output of source country, source institute, and analysis of word clusters in title, author keywords, and keywords plus. The results have shown that the USA ranked first using five publication indicators including total, single country, international, first author, and corresponding author publications. China has had the sharpest rise of publications since 2004. The top four European countries in 2008 were France, Germany, the UK, and Italy, respectively. Trend studies with word cluster analysis were performed with regards to the areas of immunology, screening methodology, behavioral sciences, economics, and meta-analysis. All those areas have shown a sharp upward rise since 2004. In addition, hypermethylation-induced inactivation of the p16 gene in the early stages of oncogenesis has been getting more interest in recent years.

Keywords

Human papillomavirus; Bibliometric; Research trend; Cervical cancer

Cite and Share

H.W. Lin,T.C. Yu,Y.S. Ho. A systemic review of human papillomavirus studies: global publication comparison and research trend analyses from 1993 to 2008. European Journal of Gynaecological Oncology. 2011. 32(2);133-140.

References

[1] Schwarz E., Freese U.K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., Hausen H.Z.: “Structure and transcription of human papillomavirus sequences in cervical-carcinoma cells”. Nature, 1985, 314, 111.

[2] Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V. et al.: “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide”. J. Pathol., 1999, 189, 12.

[3] Werness B.A., Levine A.J., Howley P.M.: “Association of human papillomavirus type-16 and type-18 e6 proteins with p53”. Science, 1990, 248, 76.

[4] Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M.: “The HPV-16 E6 and E6-AP complex functions as a Ubiquitin-protein Ligase in the Ubiquitination of p53”. Cell., 1993, 80, 495.

[5] Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F. et al.: “Role of a p53 polymorphism in the development of human papillomavirus-associated cancer”. Nature, 1998, 393, 229.

[6] Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B. et al.: “A controlled trial of a human papillomavirus type 16 vaccine’. N. Engl. J. Med., 2002, 347, 1645.

[7] Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A. et al.: “Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomisedcontrolled trial”. Lancet, 2004, 364, 1757.

[8] Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romonowski B., Roteli-Martins C.M. et al.: “Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial”. Lancet, 2006, 367, 1247.

[9] Ugolini D., Puntoni R., Perera F.P., Schulte P.A., Bonassi S.: “A bibliometric analysis of scientific production in cancer molecular epidemiology”. Carcinogenesis, 2007, 28, 1774.

[10] Orth G., Favre M., Croissant O.: “Characterization of a new type of human papillomavirus that causes skin warts”. J. Virol., 1977, 24, 108.

[11] Orth G., Breitburd F., Favre M.: “Evidence for antigenic determinants shared by the structural polypeptides of (shope) rabbit papillomavirus and human papillomavirus type-1”. Virology, 1978, 91, 243.

[12] Orth G., Jablonska S., Jarzabekchorzelska M., Obalek S., Rzesa G., Favre M., Croissant O.: “Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis”. Cancer Res., 1979, 39, 1074.

[13] Gissmann L., Devilliers E.M., Hausen H.Z.: “Analysis of human genital warts (condylomata-acuminata) and other genital tumors for human papillomavirus type-6 DNA”. Int. J. Cancer, 1982, 29, 143.

[14] Gissmann L., Wolnik L., Ikenberg H., Koldovsky U., Schnurch H. G., Zurhausen H.: “Human papillomavirus type-6 and type-11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers”. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences, 1983, 80, 560.

[15] Schwarz E., Durst M., Demankowski C., Lattermann O., Zech R., Wolfsperger E. et al.: “DNA-sequence and genome organization of genital human papillomavirus type-6B”. Embo J., 1983, 2, 2341.

[16] Wagner D., Ikenberg H., Boehm N., Gissmann L.: “Identification of human papillomavirus in cervical swabs by deoxyribonucleicacid insitu hybridization”. Obstet. Gynecol., 1984, 64, 767.

[17] Durst M., Kleinheinz A., Hotz M., Gissmann L.: “The physical state of human papillomavirus type-16 DNA in benign and malignant genital tumors”. J. Gen. Virol., 1985, 66, 1515.

[18] Bosch F.X., Manos M.M., Muñoz N., Sherman M., Jansen A.M., Peto J. et al.: “Prevalence of human papillomavirus in cervical-cancer: A worldwide perspective”. J. Natl. Cancer Inst., 1995, 87, 796.

[19] Li L.L., Ding G.H., Feng N., Wang M.H., Ho Y.S.: “Global stem cell research trend: Bibliometric analysis as a tool for mappingof trends from 1991 to 2006”. Scientometrics, 2009, 80, 41.

[20] Chen S.R., Chiu W.T., Ho Y.S.: “Asthma in children: Mapping the literature by bibliometric analysis”. Revue Française d’Allergologie et d’Immunologie Clinique, 2005, 45, 442.

[21] Hsieh W.H., Chiu W.T., Lee Y.S., Ho Y.S.: “Bibliometric analysis of patent ductus arteriosus treatments”. Scientometrics, 2004, 60, 205.

[22] López-Illescas C., de Moya-Anegón F., Moed H.F.: “The actual citation impact of European oncological research”. Eur. J. Cancer, 2008, 44, 228.

[23] Rodríguez K., Moreiro J.A.: “The growth and development of research in the field of ecology as measured by dissertation title analysis”. Scientometrics, 1996, 35, 59.

[24] Xie S.D., Zhang J., and Ho Y.S.: “Assessment of world aerosol research trends by bibliometric analysis”. Scientometrics, 2008, 77, 113.

[25] Chiu W.T., Ho Y.S.: “Bibliometric analysis of tsunami research”. Scientometrics, 2007, 73, 3.

[26] Ho Y.S.: “Bibliometric analysis of adsorption technology in environmental science”. J. Environ. Protect. Sci., 2007, 1, 1.

[27] Garfield E.: “KeyWords Plus-ISIS breakthrough retrieval method. 1. Expanding your searching power on current-contents on diskette”. Curr. Contents, 1990, 32, 5.

[28] Chuang K.Y., Huang Y.L., Ho Y.S.: “A bibliometric and citation analysis of stroke-related research in Taiwan”. Scientometrics, 2007, 72, 201.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top